Emanuele Bosi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Randomized Controlled Trial

Tyrosine Kinase

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Valentino Cherubini, Enza Mozzillo, Dario Iafusco, Riccardo Bonfanti, Carlo Ripoli, Flavia Pricci, Olimpia Vincentini, Umberto Agrimi, Marco Silano, Francesca Ulivi, Antonio D'Avino, Vito Lampasona, Emanuele Bosi
Follow-up and monitoring programme in children identified in early-stage type 1 diabetes during screening in the general population of Italy. Diabetes, obesity & metabolism (2024)
Aurora Merolla, Rebecca De Lorenzo, Giulia Ferrannini, Cristina Renzi, Francesca Ulivi, Elena Bazzigaluppi, Vito Lampasona, Emanuele Bosi
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol. BMJ open 14 (3) (2024)
Aurora Merolla, Rebecca De Lorenzo, Giulia Ferrannini, Cristina Renzi, Francesca Ulivi, Elena Bazzigaluppi, Vito Lampasona, Emanuele Bosi
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol. BMJ open 14 (3) (2024)
Aurora Merolla, Rebecca De Lorenzo, Giulia Ferrannini, Cristina Renzi, Francesca Ulivi, Elena Bazzigaluppi, Vito Lampasona, Emanuele Bosi
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol. BMJ open 14 (3) (2024)
Amelia Caretto, Edoardo Errichiello, Maria Grazia Patricelli, Orsetta Zuffardi, Giulia Cristel, Silvia Ravelli, Marcella Sirtori, Marina Scavini, Emanuele Bosi, Sabina Martinenghi
Transcutaneous electrical stimulation therapy and genetic analysis in Dercum's disease: A pilot study. Medicine 100 (51) (2022)
Lorenzo Piemonti, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, Pozzilli Paolo, Francesco Giorgino, Efisio Cossu, Luisa Daffonchio, Giovanni Goisis, Pier Adelchi Ruffini, Anna Rita Maurizi, Flavio Mantelli, Marcello Allegretti
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial. Diabetes, obesity & metabolism 24 (9) (2022)
Julien Da Silva, Emanuele Bosi, Johan Jendle, Arcelia Arrieta, Javier Castaneda, Benyamin Grossman, Toni L Cordero, John Shin, Ohad Cohen
Real-world performance of the MiniMed™ 670G system in Europe. Diabetes, obesity & metabolism 23 (8) (2021)
Andrea Mario Bolla, Elena Butera, Silvia Pellegrini, Amelia Caretto, Riccardo Bonfanti, Raffaella Alessia Zuppardo, Graziano Barera, Giulia Martina Cavestro, Valeria Sordi, Emanuele Bosi
Expression of glucose transporters in duodenal mucosa of patients with type 1 diabetes. Acta diabetologica 57 (11) (2020)
Vito Lampasona, Massimiliano Secchi, Marina Scavini, Elena Bazzigaluppi, Cristina Brigatti, Ilaria Marzinotto, Alberto Davalli, Amelia Caretto, Andrea Laurenzi, Sabina Martinenghi, Chiara Molinari, Giordano Vitali, Luigi Di Filippo, Alessia Mercalli, Raffaella Melzi, Cristina Tresoldi, Patrizia Rovere Querini, Giovanni Landoni, Fabio Ciceri, Emanuele Bosi, Lorenzo Piemonti
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia 63 (12) (2020)
Emanuele Bosi, Carlo Bosi, Patrizia Rovere Querini, Nicasio Mancini, Giliola Calori, Annalisa Ruggeri, Cecilia Canzonieri, Luciano Callegaro, Massimo Clementi, Francesco De Cobelli, Massimo Filippi, Marco Bregni
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial. Trials 21 (1) (2020)